DrugPatentWatch Database Preview
Rubicon Res Pvt Ltd Company Profile
What is the competitive landscape for RUBICON RES PVT LTD, and what generic and branded alternatives to RUBICON RES PVT LTD drugs are available?
RUBICON RES PVT LTD has five approved drugs.
There is one tentative approval on RUBICON RES PVT LTD drugs.
Summary for Rubicon Res Pvt Ltd
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Rubicon Res Pvt Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon Res Pvt Ltd | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 208170-002 | May 31, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Rubicon Res Pvt Ltd | BACLOFEN | baclofen | TABLET;ORAL | 209102-003 | Nov 28, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Rubicon Res Pvt Ltd | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 200981-002 | Oct 28, 2014 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Rubicon Res Pvt Ltd | BACLOFEN | baclofen | TABLET;ORAL | 209102-001 | Nov 28, 2017 | RX | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Rubicon Res Pvt Ltd | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 204882-003 | Jun 11, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Rubicon Res Pvt Ltd | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 204883-001 | Jun 20, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
